Department of Clinical Chemistry, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
Research Article
Vaccine Candidates, Immuno-Dominant Antigens and Potent Vaccine Adjuvants for Preventing Cutaneous Leishmaniasis: A Systematic Review
Author(s): Abiy Ayele Angelo*, Gashaw Adane, Yeshambel Belyhun, Bisrat Birke Teketelew, Dereje Mengesha Berta, Elias Chane, Negesse Cherie and Mesele Nigus
Cutaneous leishmaniasis (CL) is the most common clinical form of leishmaniasis that causes skin
disease. Currently, there is no licensed prophylactic vaccine for CL, as the mechanisms of healing
and memory T-cell responses that develop after infection with CL are far from fully understood. A
review of the published articles identifying CL vaccine candidates, immuno-dominant antigens and
potent vaccine adjuvants is needed to provide comprehensive information. Therefore, we aimed to
review vaccine candidates, immuno-dominant antigens and potent vaccine adjuvants for preventing
cutaneous leishmaniasis.
First-generation vaccine candidates showed complete protection of the specified animal model. They
induced strong T-cell mediated and antibody-mediated humoral immune responses (e.g. Curdlan
dectin-1, Total Leishmania Antigen (TLA) and L. infantum heat shock.. View more»